Online message boards giving medical advice about implanted cardiac defibrillators (ICDs) are only accurate about half the time, according to research set to be presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions 2018.

Insurance companies are beginning to decide what they’ll charge and whether to participate on the Affordable Care Act (ACA) exchanges for 2019, with Matt Eyles, the next CEO of America’s Health Insurance Plans (AHIP), saying it’s “not a pretty picture right now” for individual market insurers.

The cost of informal caregiving for Americans with heart disease and stroke is projected to more than double over the next two decades, increasing from $61 billion in 2015 to $128 billion by 2035, according to a policy statement published April 9 in Circulation.

Bracco Diagnostics has filed a complaint with the U.S. International Trade Commission (ITC) against radiopharmaceutical firm Jubilant DraxImage and two affiliates, citing patent infringement on its rubidium-82 generators.

For all the attention given to forays from Amazon, Apple and Walmart into the healthcare space, traditional providers are more worried about the continued expansion of UnitedHealthGroup’s Optum into clinical care, according to an article in Bloomberg.

Imaging giant Bracco Diagnostics has filed a complaint with the U.S. International Trade Commission against Jubilant DraxImage, a Canadian radiopharmaceutical firm, requesting the ITC halt imports of Jubilant’s Ruby-Fill rubidium-82 generators and related components.

Tustin, California-based Canon Medical Systems USA announced April 9 that it’s new Aquilion Precision ultra-high-resolution CT system has been cleared by the FDA. According to the company release, the system can improve resolution of traditional CT exams, being able to resolve anatomy as small as 150 microns.

A new bill introduced in California’s state legislature would put the state in charge of setting rates for medical services covered by private insurers, setting up a battle between consumer groups and the lobbyists for the healthcare industry.